首页 | 本学科首页   官方微博 | 高级检索  
检索        


Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B
Institution:1. Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA;2. Division of Hematology and Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA;3. Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA;4. Gene & Stem Cell Therapy Program, Centenary Institute, and Faculty of Medicine and Health, The University of Sydney, Sydney, Australia;5. Cell and Molecular Therapies, Royal Prince Alfred Hospital, Camperdown, NSW, Australia;6. Division of Hematology, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA;7. Department of Internal Medicine, Faculty of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil;8. IHTC Hemophilia Unit Cláudio Luiz Pizzigatti Corrêa, INCT do Sangue Hemocentro UNICAMP, University of Campinas, Campinas, São Paulo, Brazil;9. Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA;10. Spark Therapeutics, Philadelphia, PA, USA
Abstract:
><ol class=
  • Download : Download high-res image (108KB)
  • Download : Download full-size image
  • Keywords:AAV  adeno-associated virus  neutralizing antibody  hemophilia  clinical gene therapy  gene therapy
    本文献已被 ScienceDirect 等数据库收录!
    设为首页 | 免责声明 | 关于勤云 | 加入收藏

    Copyright©北京勤云科技发展有限公司  京ICP备09084417号